Excelsior Medical Co., Ltd. (TPE:4104)
84.80
-3.60 (-4.07%)
Sep 9, 2025, 2:36 PM CST
Excelsior Medical Revenue
Excelsior Medical had revenue of 2.17B TWD in the quarter ending June 30, 2025, with 0.38% growth. This brings the company's revenue in the last twelve months to 8.65B, up 2.95% year-over-year. In the year 2024, Excelsior Medical had annual revenue of 8.54B with 3.71% growth.
Revenue (ttm)
8.65B
Revenue Growth
+2.95%
P/S Ratio
1.68
Revenue / Employee
62.71M
Employees
138
Market Cap
14.55B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 8.54B | 305.14M | 3.71% |
Dec 31, 2023 | 8.23B | 1.05B | 14.56% |
Dec 31, 2022 | 7.19B | 613.68M | 9.34% |
Dec 31, 2021 | 6.57B | -102.34M | -1.53% |
Dec 31, 2020 | 6.68B | 218.13M | 3.38% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Caliway Biopharmaceuticals | 44.83M |
PharmaEssentia | 12.63B |
Bora Pharmaceuticals Co., LTD. | 21.32B |
Lotus Pharmaceutical | 19.12B |
Lumosa Therapeutics | 37.25M |
Oneness Biotech | 112.57M |
Polaris Group | 64.02M |
Pell Bio-Med Technology | 27.43M |